At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
ARGOS-IO Sensor Pressure Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Open-label, Multicenter Clinical Follow-up Investigation of the ARGOS-01 and ARGOS-02 Patients to Assess the Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)
In Brief
A clinical study evaluating ARGOS-IO Sensor Pressure System for Primary Open-angle Glaucoma. Completed, enrolled 16 participants across 4 sites.
Detailed Summary
The purpose of this study is to evaluate the long-term safety and performance of the ARGOS-IO system in patients with Primary Open Angle Glaucoma (POAG)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Open-angle Glaucoma
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartAug 2018
First PostedAug 2018
Primary CompletionApr 2022
TodayJul 2026
First PostedAug 29, 2018
Enrollment StartAug 15, 2018
Primary CompletionApr 27, 2022
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 7.8 years ago
Interventions
ARGOS-IO Sensor Pressure Systemdevice
The ARGOS-IO Pressure sensor have been additionally implanted during local routine working procedures for cataract surgery in Patients with Primary Open Angle Glaucoma (POAG) and indicated cataract surgery in previous studies ARGOS-01 and ARGOS-02